Joshua Zeidner
unclineberger.org
0000-0002-9014-1514
University of North Carolina, Lineberger Comprehensive Cancer Center
2 papers found
Refreshing results…
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML)
Missing publications? Search for publications with a matching author name.